Published Articles - 2017
Biosimilars and Their Structural Characterization
American Pharmaceutical Review, December 2017
Authors
Robert F. Carney, MS, Principal Mass Spec Scientist, Eurofins Lancaster Laboratories
Richard Gill Jr., PhD, Senior Scientist, Eurofins Lancaster Laboratories
Zsuzsa Lakos, Principal Scientist, Eurofins Lancaster Laboratories
John L. Snyder, Research Fellow Group Leader, Eurofins Lancaster Laboratories
David Zuluaga, MS, Scientist, Eurofins Lancaster Laboratories
Maximizing Strategic External Service Provider Relationships In-House
Contract Pharma, October 2017
Author
Beth DiPaolo, Eurofins Lancaster Laboratories PSS Insourcing Solutions
Going All In: Drivers for Insourcing Professional Scientific Services
Contract Pharma, September 2017
Author
Patricia Grace, Eurofins BioPharma Product Testing
Electronic Laboratory Notebooks – An Essential Tool for CROs
American Pharmaceutical Review, August 2017
Interviewee
John D. Jegla, Ph.D., Manager, Pharma Electronic Notebook, Eurofins Lancaster Laboratories
The Advantages of LC/MS in Identifying Residual Impurities in Biopharmaceuticals
International Pharmaceutical Industry, Summer 2017
Author
Fergus Hall, Ph.D., Section Manager, Pharmaceutical Chemistry, Eurofins BioPharma Product Testing
Complex Characters
European Biopharmaceutical Review July 2017, pages 74-79. © Samedan Ltd
Author
Dr. Jon S Kauffman, Senior Director, Biochemistry, Method Development & Validation and Protocol Development and Technical Writing, Eurofins Lancaster Laboratories
Overcoming the challenges of characterizing bioprocess residual impurities in biologics using HPLC/MS
Contract Pharma, May 2017
Author
Fergus Hall, Section Manager, Pharmaceutical Chemistry, Eurofins BioPharma Product Testing
PSS Insourcing Solutions® Managed Services Solves Staffing Challenges for Bio/Pharmaceutical Companies
Pharmaceutical Daily News, CPhI 2017
Interviewee
Beth DiPaolo, MA, President, Eurofins Lancaster Laboratories Professional Scientific Services
A QUICK Guide to Selecting a CMO
PDA Letter May 2017, pages 42-43
Author
Brittany Cloud, Group Leader, Quality Compliance, Eurofins Lancaster Laboratories
Predictions for the future of formulation
European Pharmaceutical Review, March, 2017
Interviewee
Tom Kovalcik, Vice President, Manufacturing and Development at Eurofins Advantar
Managing E&L Unknown Compounds
European Biopharmaceutical Review April 2017, pages 14-15. © Samedan Ltd
Authors
Simone Carrara, E&L Lab Manager
Andrew Blakinger, Manager, Extractables & Leachables Testing
Thomas Lehman, Ph.D., Director, Method Development and Validation and Extractables and Leachables